The Association between Atherosclerotic Disease Risk Factors and Serum 25-Hydroxyvitamin D Concentration in Japanese Subjects
Recent studies have described that vitamin D deficiency/insufficiency is associated with hypertension, insulin resistance, and dyslipidemia, which are major components of metabolic syndrome causing atherosclerosis. Therefore, we investigated the relationship between serum 25-hydroxyvitamin D [25(OH)...
Saved in:
Published in | Journal of Nutritional Science and Vitaminology Vol. 69; no. 3; pp. 176 - 183 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Center for Academic Publications Japan
30.06.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0301-4800 1881-7742 |
DOI | 10.3177/jnsv.69.176 |
Cover
Abstract | Recent studies have described that vitamin D deficiency/insufficiency is associated with hypertension, insulin resistance, and dyslipidemia, which are major components of metabolic syndrome causing atherosclerosis. Therefore, we investigated the relationship between serum 25-hydroxyvitamin D [25(OH)D] concentration and atherosclerotic disease risk factors in healthy Japanese adults. In the present cross-sectional study, 1,177 subjects (348 males and 829 females) aged 20–72 y living in Japan (34.7–35.0ºN) were evaluated for vitamin D status by measuring serum 25(OH)D concentration. Atherosclerotic disease risk factors were defined as the presence of two or more of the following three risk factors: high blood pressure, dyslipidemia, and hyperglycemia. The percentages of vitamin D deficient and insufficient subjects were 33% and 46% in males and 59% and 32% in females, respectively. Subjects with atherosclerotic disease risk factors were significantly older and had higher BMI than those without it in both sexes. Male subjects with atherosclerotic disease risk factors had significantly lower physical activity and serum 25(OH)D concentration than those without it. In a logistic regression analysis adjusted for confounding factors, serum 25(OH)D concentration showed a significant inverse association with risk factors of atherosclerotic disease in males (OR=0.951, 95%CI: 0.906–0.998), but not in females. A covariance structure analysis also suggested that serum 25(OH)D level has a direct association with risk factors of atherosclerotic disease. In conclusion, we have demonstrated that low serum 25(OH)D level is a significant factor for increased atherosclerotic disease risk factors in males. |
---|---|
AbstractList | Recent studies have described that vitamin D deficiency/insufficiency is associated with hypertension, insulin resistance, and dyslipidemia, which are major components of metabolic syndrome causing atherosclerosis. Therefore, we investigated the relationship between serum 25-hydroxyvitamin D [25(OH)D] concentration and atherosclerotic disease risk factors in healthy Japanese adults. In the present cross-sectional study, 1,177 subjects (348 males and 829 females) aged 20–72 y living in Japan (34.7–35.0ºN) were evaluated for vitamin D status by measuring serum 25(OH)D concentration. Atherosclerotic disease risk factors were defined as the presence of two or more of the following three risk factors: high blood pressure, dyslipidemia, and hyperglycemia. The percentages of vitamin D deficient and insufficient subjects were 33% and 46% in males and 59% and 32% in females, respectively. Subjects with atherosclerotic disease risk factors were significantly older and had higher BMI than those without it in both sexes. Male subjects with atherosclerotic disease risk factors had significantly lower physical activity and serum 25(OH)D concentration than those without it. In a logistic regression analysis adjusted for confounding factors, serum 25(OH)D concentration showed a significant inverse association with risk factors of atherosclerotic disease in males (OR=0.951, 95%CI: 0.906–0.998), but not in females. A covariance structure analysis also suggested that serum 25(OH)D level has a direct association with risk factors of atherosclerotic disease. In conclusion, we have demonstrated that low serum 25(OH)D level is a significant factor for increased atherosclerotic disease risk factors in males. |
Author | YASUOKA, Akane TANAKA, Kiyoshi WATANABE, Yasuyoshi TSUGAWA, Naoko URA, Chihiro KUWABARA, Akiko OGASAWARA, Honami MIZUNO, Kei |
Author_xml | – sequence: 1 fullname: MIZUNO, Kei organization: Department of Healthcare Solution Science, Graduate School of Science, Technology and Innovation, Kobe University – sequence: 1 fullname: WATANABE, Yasuyoshi organization: Department of Essential Healthcare Science, Graduate School of Science, Technology and Innovation, Kobe University – sequence: 1 fullname: TANAKA, Kiyoshi organization: Research Support Center, Shizuoka General Hospital – sequence: 1 fullname: KUWABARA, Akiko organization: Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University – sequence: 1 fullname: URA, Chihiro organization: Department of Packaged Food Engineering, Toyo College of Food Technology – sequence: 1 fullname: OGASAWARA, Honami organization: Department of Health and Nutrition, Osaka Shoin Women’s University – sequence: 1 fullname: YASUOKA, Akane organization: Department of Clinical Nutrition, Graduate School of Comprehensive Rehabilitation, Osaka Prefecture University – sequence: 1 fullname: TSUGAWA, Naoko organization: Department of Health and Nutrition, Osaka Shoin Women’s University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37394422$$D View this record in MEDLINE/PubMed |
BookMark | eNptkM1PAjEQxRuDEURP3k3vZrHd7kf3YkJARWNionhuut1ZKUKXtAXl4P9uyQoH42WaTH_vZd47RR3TGEDogpIBo3l-PTduM8iKAc2zI9SjnNMoz5O4g3qEERolnJAuOnVuTkhS8ISfoC7LWZEkcdxD39MZ4KFzjdLS68bgEvwngMFDPwPbOLUI02uFx9qBdIBftPvAd1L5xjosTYVfwa6XOE6jybayzdd2o71caoPHeNQYBcbb1jisHuVKGggmr-tyDsq7M3Rcy4WD89-3j97ubqejSfT0fP8wGj5FKk1THyUEgCUVz7JKQSazuuY14UwVhWSKZHGIwlnNIC0VlTVXlORlWTHCoeQ8jxnro8vWd7Uul1CJldVLabdi30MAaAuokNlZqIUKMXZ3h_P1QlAidl2LXdciK0ToOmiu_mj2tv_TNy09d16-w4GVNrS7gAPLfgWHDzWTVoBhP2dlmfA |
CitedBy_id | crossref_primary_10_1016_j_vph_2024_107416 crossref_primary_10_1016_j_clnu_2024_06_031 |
Cites_doi | 10.1093/ajcn/87.4.1080S 10.1016/j.nut.2016.02.024 10.1111/jdi.13086 10.1507/endocrj.47.383 10.1038/ijo.2010.232 10.1021/ac048249c 10.2147/DMSO.S275847 10.1590/1806-9282.63.06.550 10.1248/bpb.24.738 10.1371/journal.pone.0068689 10.1096/fj.02-0424fje 10.2337/dc06-2438 10.1038/s41598-017-17397-9 10.1111/j.1365-2362.2012.02706.x 10.1111/jgs.14694 10.1016/j.numecd.2019.12.006 10.2337/dc09-0209 10.1016/j.numecd.2012.02.004 10.1186/s12877-019-1118-y 10.1016/j.clnu.2021.02.031 10.1111/j.1464-5491.2006.01858.x 10.3390/nu12030743 10.1016/j.chembiol.2016.12.017 10.1016/j.metabol.2014.11.010 10.1111/obr.12793 10.3945/ajcn.116.140392 10.7759/cureus.17419 10.1037/0022-3514.51.6.1173 10.1172/JCI0215219 10.1210/jc.2016-3743 10.1038/s41598-020-69762-w 10.1016/j.dsx.2015.02.014 10.1210/jc.2013-3577 10.1093/gerona/glx117 10.1111/obr.13223 10.1210/er.2012-1055 10.1016/j.plipres.2011.05.001 10.1161/CIRCOUTCOMES.112.967604 |
ContentType | Journal Article |
Copyright | 2023 by the Center for Academic Publications Japan |
Copyright_xml | – notice: 2023 by the Center for Academic Publications Japan |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM |
DOI | 10.3177/jnsv.69.176 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1881-7742 |
EndPage | 183 |
ExternalDocumentID | 37394422 10_3177_jnsv_69_176 article_jnsv_69_3_69_176_article_char_en |
Genre | Journal Article |
GroupedDBID | --- -~X .55 2WC 53G 5GY 5RE AAFWJ AAWTL ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 F5P JSF JSH KQ8 OK1 RJT RZJ TR2 X7M AAYXX CITATION CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c555t-40ee34d866dce6a6ff8f083c99a3c06244283f3e5bc1af8c107bbd308eb887233 |
ISSN | 0301-4800 |
IngestDate | Thu Apr 03 07:04:09 EDT 2025 Thu Apr 24 23:11:39 EDT 2025 Tue Jul 01 01:41:30 EDT 2025 Wed Sep 03 06:30:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | metabolic syndrome vitamin D insufficiency atherosclerotic disease risk factors 25-hydroxyvitamin D Japanese |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c555t-40ee34d866dce6a6ff8f083c99a3c06244283f3e5bc1af8c107bbd308eb887233 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jnsv/69/3/69_176/_article/-char/en |
PMID | 37394422 |
PageCount | 8 |
ParticipantIDs | pubmed_primary_37394422 crossref_citationtrail_10_3177_jnsv_69_176 crossref_primary_10_3177_jnsv_69_176 jstage_primary_article_jnsv_69_3_69_176_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023/06/30 |
PublicationDateYYYYMMDD | 2023-06-30 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023/06/30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Journal of Nutritional Science and Vitaminology |
PublicationTitleAlternate | J Nutr Sci Vitaminol |
PublicationYear | 2023 |
Publisher | Center for Academic Publications Japan |
Publisher_xml | – name: Center for Academic Publications Japan |
References | 25) Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, Morini S, Leonetti F, Cavallo MG. 2013. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One 8: e68689. 29) Yu S, Song L, Wei Q, Lv Y, Wan Z. 2021. Dose-response relationship between serum 25-hydroxyvitamin D and the risk of metabolic syndrome. Clin Nutr 40: 1530-1536. 28) Hajhashemy Z, Shahdadian F, Moslemi E, Mirenayat FS, Saneei P. 2021. Serum vitamin D levels in relation to metabolic syndrome: A systematic review and dose-response meta-analysis of epidemiologic studies. Obes Rev 22: e13223. 5) Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 2002. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238. 33) Chun H, Kim GD, Doo M. 2020. Differences in the association among the vitamin D concentration, dietary macronutrient consumption, and metabolic syndrome depending on pre-and postmenopausal status in Korean women: A cross-sectional study. Diabetes Metab Syndr Obes Targets Ther 13: 3601-3609. 35) Lu Y, Liu M, Pei Y, Li J, Tian H, Cheng X, Fang F, Sun B, Xiao H, Li N, Miao X, Li C. 2015. Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China. Int J Clin Exp Med 8: 13790-13796. 37) Wang L, Song Y, Manson JAE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD. 2012. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5: 819-829. 3) Prasad P, Kochhar A. 2016. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr Clin Res Rev 10: 105-112. 7) Maestro B, Campion J, Davila N, Calle C. 2000. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47: 383-391. 40) Theik NWY, Raji OE, Shenwai P, Shah R, Kalluri SR, Bhutta TH, Hannoodee H, Al Khalili M, Khan S. 2021. Relationship and effects of vitamin D on metabolic syndrome: A systematic review. Cureus 13: e17419. 13) Fernandes MR, Barreto WDRJ. 2017. Association between physical activity and vitamin D: A narrative literature review. Rev Assoc Med Bras 63: 550-556. 32) Weldegiorgis TZ, Hidru TH, Yang XL, Xia YL, Ma L, Li HH. 2020. Association between serum 25-hydroxyvitamin D concentrations and metabolic syndrome in the middle-aged and elderly Chinese population in Dalian, northeast China: A cross-sectional study. J Diabetes Investig 11: 184-191. 18) Tsugawa N, Suhara Y, Kamao M, Okano T. 2005. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 77: 3001-3007. 36) Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, Gu H, Wang Y, Wang Y, Liu G. 2017. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: Dose-response meta-analysis of prospective studies. Am J Clin Nutr 105: 810-819. 8) Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W. 2012. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Eur J Clin Invest 42: 1189-1196. 26) Reis JP, Von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. 2007. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30: 1549-1555. 16) Martinez-Gomez D, Guallar-Castillon P, Higueras-Fresnillo S, Garcia-Esquinas E, Lopez-Garcia E, Bandinelli S, Rodríguez-Artalejo F. 2018. Physical activity attenuates total and cardiovascular mortality associated with physical disability: A national cohort of older adults. J Gerontol A Biol Sci Med Sci 73: 240-247. 19) Higashi T, Awada D, Shimada K. 2001. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull 24: 738-743. 9) Asano L, Watanabe M, Ryoden Y, Usuda K, Yamaguchi T, Khambu B, Takashima M, Sato S, Sakai J, Nagasawa K, Uesugi M. 2017. Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP/SCAP. Cell Chem Biol 24: 207-217. 6) Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17: 509-511. 10) Jorde R, Grimnes G. 2011. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50: 303-312. 24) Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. 2009. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32: 1278-1283. 39) Bahrami LS, Ranjbar G, Norouzy A, Arabi SM. 2020. Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis. Sci Rep 10: 12923. 20) The Japan Endocrine Society, The Japanese Society for Bone and Mineral Research, Ministry of Health, Labour and Welfare, Research Project for Overcoming Intractable Diseases Research Team on Abnormalities in Hormone Receptor Mechanisms. 2017. Guidelines for determining vitamin D deficiency and insufficiency. Japanese Journal of Endocrinology 93: 1-10 (in Japanese). 12) Akter S, Eguchi M, Kurotani K, Kochi T, Kashino I, Ito R, Kuwahara K, Tsuruoka H, Kabe I, Mizoue T. 2017. Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study. Nutrition 36: 26-32. 1) Alberti KGMM, Zimmet P, Shaw J. 2006. Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480. 31) Bea JW, Jurutka PW, Hibler EA, Lance P, Martínez ME, Roe DJ, Sardo Molmenti CL, Thompson PA, Jacobs ET. 2015. Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64: 447-459. 30) Kim MH, Lee J, Ha J, Jo K, Lim DJ, Lee JM, Chang SA, Kang MI, Cha BY. 2018. Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function. Sci Rep 8: 1149. 21) The Examination Committee of Criteria for Metabolic Syndrome. 2005. Definition and criteria of metabolic syndrome. Nihon Naika Gakkai Zasshi 94: 794-809 (in Japanese). 27) Majumdar V, Nagaraja D, Christopher R. 2011. Vitamin D status and metabolic syndrome in Asian Indians. Int J Obes 35: 1131-1134. 41) Su Y, Leung J, Lee J, Ho KF, Kwok T. 2020. The effect of physical activity on dose-relationship between serum 25-hydroxyvitamin D and cardiovascular health events in older adults. Nutr Metab Cardiovasc Dis 30: 656-665. 2) Holick MF, Chen TC. 2008. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87: 1080-1086. 34) Mauvais-Jarvis F, Clegg DJ, Hevener AL. 2013. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34: 309-338. 14) Chin K, Zhao D, Tibuakuu M, Martin SS, Ndumele CE, Florido R, Windham BG, Guallar E, Lutsey PL, Michos ED. 2017. Physical activity, vitamin D, and incident atherosclerotic cardiovascular disease in whites and blacks: The ARIC Study. J Clin Endocrinol Metab 102: 1227-1236. 23) Lee SJ, Lee EY, Lee JH, Kim JE, Kim KJ, Rhee Y, Kim HC, Youm Y, Kim CO. 2019. Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: The Korean Urban Rural Elderly cohort study. BMC Geriatr 19: 102. 22) Baron RM, Kenny DA. 1986. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51: 1173-1182. 11) Ju SY, Jeong HS, Kim DH. 2014. Blood vitamin D status and metabolic syndrome in the general adult population: A dose-response meta-analysis. J Clin Endocrinol Metab 99: 1053-1063. 4) Asakura K, Etoh N, Imamura H, Michikawa T, Nakamura T, Takeda Y, Mori S, Nishiwaki Y. 2020. Vitamin D status in Japanese adults: Relationship of serum 25-hydroxyvitamin D with simultaneously measured dietary vitamin D intake and ultraviolet ray exposure. Nutrients 12: 743. 38) Marquina C, Mousa A, Scragg R, de Courten B. 2019. Vitamin D and cardiometabolic disorders: a review of current evidence, genetic determinants and pathomechanisms. Obes Rev 20: 262-277. 15) Zittermann A, Borgermann J, Gummert JF, Pilz S. 2012. Future directions in vitamin D and cardiovascular research. Nutr Metab Cardiovasc Dis 22: 541-546. 17) Barengo NC, Antikainen R, Borodulin K, Harald K, Jousilahti P. 2017. Leisure-time physical activity reduces total and cardiovascular mortality and cardiovascular disease incidence in older adults. J Am Geriatr Soc 65: 504-510. 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 35 14 36 15 37 16 38 17 39 18 19 1 2 3 4 5 6 7 8 9 40 41 20 21 |
References_xml | – reference: 31) Bea JW, Jurutka PW, Hibler EA, Lance P, Martínez ME, Roe DJ, Sardo Molmenti CL, Thompson PA, Jacobs ET. 2015. Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64: 447-459. – reference: 35) Lu Y, Liu M, Pei Y, Li J, Tian H, Cheng X, Fang F, Sun B, Xiao H, Li N, Miao X, Li C. 2015. Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China. Int J Clin Exp Med 8: 13790-13796. – reference: 32) Weldegiorgis TZ, Hidru TH, Yang XL, Xia YL, Ma L, Li HH. 2020. Association between serum 25-hydroxyvitamin D concentrations and metabolic syndrome in the middle-aged and elderly Chinese population in Dalian, northeast China: A cross-sectional study. J Diabetes Investig 11: 184-191. – reference: 12) Akter S, Eguchi M, Kurotani K, Kochi T, Kashino I, Ito R, Kuwahara K, Tsuruoka H, Kabe I, Mizoue T. 2017. Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study. Nutrition 36: 26-32. – reference: 13) Fernandes MR, Barreto WDRJ. 2017. Association between physical activity and vitamin D: A narrative literature review. Rev Assoc Med Bras 63: 550-556. – reference: 8) Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W. 2012. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Eur J Clin Invest 42: 1189-1196. – reference: 27) Majumdar V, Nagaraja D, Christopher R. 2011. Vitamin D status and metabolic syndrome in Asian Indians. Int J Obes 35: 1131-1134. – reference: 9) Asano L, Watanabe M, Ryoden Y, Usuda K, Yamaguchi T, Khambu B, Takashima M, Sato S, Sakai J, Nagasawa K, Uesugi M. 2017. Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP/SCAP. Cell Chem Biol 24: 207-217. – reference: 22) Baron RM, Kenny DA. 1986. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51: 1173-1182. – reference: 17) Barengo NC, Antikainen R, Borodulin K, Harald K, Jousilahti P. 2017. Leisure-time physical activity reduces total and cardiovascular mortality and cardiovascular disease incidence in older adults. J Am Geriatr Soc 65: 504-510. – reference: 30) Kim MH, Lee J, Ha J, Jo K, Lim DJ, Lee JM, Chang SA, Kang MI, Cha BY. 2018. Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function. Sci Rep 8: 1149. – reference: 11) Ju SY, Jeong HS, Kim DH. 2014. Blood vitamin D status and metabolic syndrome in the general adult population: A dose-response meta-analysis. J Clin Endocrinol Metab 99: 1053-1063. – reference: 26) Reis JP, Von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. 2007. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30: 1549-1555. – reference: 38) Marquina C, Mousa A, Scragg R, de Courten B. 2019. Vitamin D and cardiometabolic disorders: a review of current evidence, genetic determinants and pathomechanisms. Obes Rev 20: 262-277. – reference: 40) Theik NWY, Raji OE, Shenwai P, Shah R, Kalluri SR, Bhutta TH, Hannoodee H, Al Khalili M, Khan S. 2021. Relationship and effects of vitamin D on metabolic syndrome: A systematic review. Cureus 13: e17419. – reference: 36) Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, Gu H, Wang Y, Wang Y, Liu G. 2017. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: Dose-response meta-analysis of prospective studies. Am J Clin Nutr 105: 810-819. – reference: 19) Higashi T, Awada D, Shimada K. 2001. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull 24: 738-743. – reference: 28) Hajhashemy Z, Shahdadian F, Moslemi E, Mirenayat FS, Saneei P. 2021. Serum vitamin D levels in relation to metabolic syndrome: A systematic review and dose-response meta-analysis of epidemiologic studies. Obes Rev 22: e13223. – reference: 20) The Japan Endocrine Society, The Japanese Society for Bone and Mineral Research, Ministry of Health, Labour and Welfare, Research Project for Overcoming Intractable Diseases Research Team on Abnormalities in Hormone Receptor Mechanisms. 2017. Guidelines for determining vitamin D deficiency and insufficiency. Japanese Journal of Endocrinology 93: 1-10 (in Japanese). – reference: 1) Alberti KGMM, Zimmet P, Shaw J. 2006. Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480. – reference: 16) Martinez-Gomez D, Guallar-Castillon P, Higueras-Fresnillo S, Garcia-Esquinas E, Lopez-Garcia E, Bandinelli S, Rodríguez-Artalejo F. 2018. Physical activity attenuates total and cardiovascular mortality associated with physical disability: A national cohort of older adults. J Gerontol A Biol Sci Med Sci 73: 240-247. – reference: 39) Bahrami LS, Ranjbar G, Norouzy A, Arabi SM. 2020. Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis. Sci Rep 10: 12923. – reference: 15) Zittermann A, Borgermann J, Gummert JF, Pilz S. 2012. Future directions in vitamin D and cardiovascular research. Nutr Metab Cardiovasc Dis 22: 541-546. – reference: 10) Jorde R, Grimnes G. 2011. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50: 303-312. – reference: 37) Wang L, Song Y, Manson JAE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD. 2012. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5: 819-829. – reference: 34) Mauvais-Jarvis F, Clegg DJ, Hevener AL. 2013. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34: 309-338. – reference: 25) Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, Morini S, Leonetti F, Cavallo MG. 2013. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One 8: e68689. – reference: 29) Yu S, Song L, Wei Q, Lv Y, Wan Z. 2021. Dose-response relationship between serum 25-hydroxyvitamin D and the risk of metabolic syndrome. Clin Nutr 40: 1530-1536. – reference: 2) Holick MF, Chen TC. 2008. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87: 1080-1086. – reference: 14) Chin K, Zhao D, Tibuakuu M, Martin SS, Ndumele CE, Florido R, Windham BG, Guallar E, Lutsey PL, Michos ED. 2017. Physical activity, vitamin D, and incident atherosclerotic cardiovascular disease in whites and blacks: The ARIC Study. J Clin Endocrinol Metab 102: 1227-1236. – reference: 5) Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 2002. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238. – reference: 18) Tsugawa N, Suhara Y, Kamao M, Okano T. 2005. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 77: 3001-3007. – reference: 23) Lee SJ, Lee EY, Lee JH, Kim JE, Kim KJ, Rhee Y, Kim HC, Youm Y, Kim CO. 2019. Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: The Korean Urban Rural Elderly cohort study. BMC Geriatr 19: 102. – reference: 6) Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17: 509-511. – reference: 33) Chun H, Kim GD, Doo M. 2020. Differences in the association among the vitamin D concentration, dietary macronutrient consumption, and metabolic syndrome depending on pre-and postmenopausal status in Korean women: A cross-sectional study. Diabetes Metab Syndr Obes Targets Ther 13: 3601-3609. – reference: 4) Asakura K, Etoh N, Imamura H, Michikawa T, Nakamura T, Takeda Y, Mori S, Nishiwaki Y. 2020. Vitamin D status in Japanese adults: Relationship of serum 25-hydroxyvitamin D with simultaneously measured dietary vitamin D intake and ultraviolet ray exposure. Nutrients 12: 743. – reference: 24) Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. 2009. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32: 1278-1283. – reference: 21) The Examination Committee of Criteria for Metabolic Syndrome. 2005. Definition and criteria of metabolic syndrome. Nihon Naika Gakkai Zasshi 94: 794-809 (in Japanese). – reference: 3) Prasad P, Kochhar A. 2016. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr Clin Res Rev 10: 105-112. – reference: 41) Su Y, Leung J, Lee J, Ho KF, Kwok T. 2020. The effect of physical activity on dose-relationship between serum 25-hydroxyvitamin D and cardiovascular health events in older adults. Nutr Metab Cardiovasc Dis 30: 656-665. – reference: 7) Maestro B, Campion J, Davila N, Calle C. 2000. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47: 383-391. – ident: 2 doi: 10.1093/ajcn/87.4.1080S – ident: 12 doi: 10.1016/j.nut.2016.02.024 – ident: 32 doi: 10.1111/jdi.13086 – ident: 7 doi: 10.1507/endocrj.47.383 – ident: 27 doi: 10.1038/ijo.2010.232 – ident: 18 doi: 10.1021/ac048249c – ident: 35 – ident: 33 doi: 10.2147/DMSO.S275847 – ident: 13 doi: 10.1590/1806-9282.63.06.550 – ident: 19 doi: 10.1248/bpb.24.738 – ident: 25 doi: 10.1371/journal.pone.0068689 – ident: 6 doi: 10.1096/fj.02-0424fje – ident: 26 doi: 10.2337/dc06-2438 – ident: 30 doi: 10.1038/s41598-017-17397-9 – ident: 20 – ident: 8 doi: 10.1111/j.1365-2362.2012.02706.x – ident: 17 doi: 10.1111/jgs.14694 – ident: 41 doi: 10.1016/j.numecd.2019.12.006 – ident: 24 doi: 10.2337/dc09-0209 – ident: 15 doi: 10.1016/j.numecd.2012.02.004 – ident: 23 doi: 10.1186/s12877-019-1118-y – ident: 29 doi: 10.1016/j.clnu.2021.02.031 – ident: 1 doi: 10.1111/j.1464-5491.2006.01858.x – ident: 4 doi: 10.3390/nu12030743 – ident: 9 doi: 10.1016/j.chembiol.2016.12.017 – ident: 31 doi: 10.1016/j.metabol.2014.11.010 – ident: 38 doi: 10.1111/obr.12793 – ident: 36 doi: 10.3945/ajcn.116.140392 – ident: 40 doi: 10.7759/cureus.17419 – ident: 22 doi: 10.1037/0022-3514.51.6.1173 – ident: 5 doi: 10.1172/JCI0215219 – ident: 14 doi: 10.1210/jc.2016-3743 – ident: 39 doi: 10.1038/s41598-020-69762-w – ident: 3 doi: 10.1016/j.dsx.2015.02.014 – ident: 11 doi: 10.1210/jc.2013-3577 – ident: 16 doi: 10.1093/gerona/glx117 – ident: 28 doi: 10.1111/obr.13223 – ident: 34 doi: 10.1210/er.2012-1055 – ident: 10 doi: 10.1016/j.plipres.2011.05.001 – ident: 21 – ident: 37 doi: 10.1161/CIRCOUTCOMES.112.967604 |
SSID | ssj0049848 |
Score | 2.3387415 |
Snippet | Recent studies have described that vitamin D deficiency/insufficiency is associated with hypertension, insulin resistance, and dyslipidemia, which are major... |
SourceID | pubmed crossref jstage |
SourceType | Index Database Enrichment Source Publisher |
StartPage | 176 |
SubjectTerms | 25-hydroxyvitamin D Adult atherosclerotic disease risk factors Calcifediol Cross-Sectional Studies East Asian People Female Humans Japanese Male metabolic syndrome Risk Factors Vitamin D Vitamin D Deficiency - complications Vitamin D Deficiency - epidemiology vitamin D insufficiency |
Title | The Association between Atherosclerotic Disease Risk Factors and Serum 25-Hydroxyvitamin D Concentration in Japanese Subjects |
URI | https://www.jstage.jst.go.jp/article/jnsv/69/3/69_176/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/37394422 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Nutritional Science and Vitaminology, 2023/06/30, Vol.69(3), pp.176-183 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbK4MAFAQNWfsmHiQNVShI7TnLMKFO3qgVNLQwuUeI4IhtNUJtOKhL_MX8Ez3YSkjGksYtVxY6j5Pv6_Jx87z2E9kXKhOfazEh9zzSonVhGDAupkVKbJpEfc6ay7U9nbLygx6fOaa_3q6Va2pTxkP-4Mq7kJqjCMcBVRsn-B7LNpHAAfgO-0ALC0F4b49bzbURXgfTqijWMXhUyIetIf4UZnEgd-WFVYUdpNsVqsxzYjjHeJlLPcpGV0TLLByMZCah1m7UY8hhWVVmtUpoa-e5m_Q-3dlan96_SjNQRCR_11J23-NOjL4vZex0elDXLQzAPZsGBUml-jtabbbH-2nTKrkmgzsg6HZPFp-AgOFFdwXl2XrRfZ9ik1t7VqiKZiXSlJJbdAIFaW6_utmUkwUAZ1DP1DEIbcc-zYNdAO1ZeF4Sp2ExaJttyWWv1t3RZncsLC9Gfts_y9cWQ-cPmnE6m7ooHoRwVMj8ksoGhYd0hA-mAt7fQbdt1tajgaFL7DdT3VK235o50NKm88pvWdTv-050z2ELI3BCdLZFyjeb30b0KfBzo6z9APZE_RLtBHpXFcotfYaUyVsDvop_AWdziLK44iy9xFlecxZKzuOIsBiJhxVn8F2fxCHc4i-FQzVlcc_YRWhy-m78dG1UJEIM7jlMa1BSC0MRjLOGCRSxNvRQ2Ddz3I8JNBr4puMcpEU7MrSj1uGW6cZwQ0xMxrJ42IY_RTl7kYg_hmHJOwWR5KSeURMy3UptbiWNG1PSjNO6j1_WDDXmVH1-WafkWwj5ZotDgCij00X4z-LtOC3P1MFcj1Ay6Lkf66ImGtDmTuDKG3baf3njOZ-jun3_cc7RTrjbiBbjUZfxSMRHa2Yfpb4ir2vo |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Association+between+Atherosclerotic+Disease+Risk+Factors+and+Serum+25-Hydroxyvitamin+D+Concentration+in+Japanese+Subjects&rft.jtitle=Journal+of+Nutritional+Science+and+Vitaminology&rft.au=MIZUNO%2C+Kei&rft.au=WATANABE%2C+Yasuyoshi&rft.au=TANAKA%2C+Kiyoshi&rft.au=KUWABARA%2C+Akiko&rft.date=2023-06-30&rft.pub=Center+for+Academic+Publications+Japan&rft.issn=0301-4800&rft.eissn=1881-7742&rft.volume=69&rft.issue=3&rft.spage=176&rft.epage=183&rft_id=info:doi/10.3177%2Fjnsv.69.176&rft.externalDocID=article_jnsv_69_3_69_176_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4800&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4800&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4800&client=summon |